First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers

First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers

Abstract Background With poor prognosis and limited treatment options for advanced hepatocellular carcinoma (HCC), development of novel therapeutic agents is urgently needed. This single-arm phase I study sought to assess the safety and preliminary efficacy of icaritin in human as a potential oral i...

Full description

Bibliographic Details
Main Authors: Ying Fan, Shu Li, Xiaoyan Ding, Jian Yue, Jun Jiang, Hong Zhao, Rui Hao, Weiliang Qiu, Kezhen Liu, Ying Li, Shengdian Wang, Limin Zheng, Bin Ye, Kun Meng, Binghe Xu
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Cancer
Subjects:
Small molecule immune modulation
Phase I trial in advanced hepatocellular carcinoma
Online Access:http://link.springer.com/article/10.1186/s12885-019-5471-1

Internet

http://link.springer.com/article/10.1186/s12885-019-5471-1

Similar Items